TECH OUTLOOK 6MAY - 2022EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe pharmaceutical industry has always prioritised quality assurance (QA) in its daily operations. But with the intermittent pandemic, pharma companies have been taking extra steps to enhance their vigilance over the course of which they increasingly recognise that much more can still be done to improve the quality management processes. To make this possible, pharmaceutical companies bank on utilising smart quality techniques augmented by cutting-edge technologies like artificial intelligence (AI), machine learning (ML), and big data. These techniques promise to make their quality processes more efficient and safer.Notably, single-use technology will play a pivotal role on that front. Adding single-use systems to production can be really advantageous for manufacturers. As no cleaning is required for inherently sterile components, manufacturers can switch quickly from one product to the next or from one batch to the next without risking contamination. Similarly, deep learning technology also promises to be a silver bullet in that regard by enabling the identification of products or processes that do not meet the quality standards. At the same time, going forward, technologies like virtual reality (VR) that facilitate remote inspections and virtual training will be ever more critical in ensuring much-needed 360-degree QA services, such as FDA inspections and international meetings.In this edition of Pharma Tech Outlook, we bring you the story of some of the top quality assurance service companies in Europe and UK that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the ideal assurance service company that fits your business requirements.Let us know your thoughts!Tech-Driven 360-Degree Quality AuditingCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.MAY - 02 - 2022, Vol 08 - Issue 04 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Disclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsEditor-in-ChiefStacey SmithVisualizerRonald DonovanAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, TECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >